ag 1879 has been researched along with Metastase in 4 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
Excerpt | Relevance | Reference |
---|---|---|
"We tested the hypotheses that Src tyrosine kinase overactivity represents a chemoresistance mechanism and that Src inhibition may enhance gemcitabine cytotoxicity in pancreatic adenocarcinoma cells." | 7.72 | Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. ( Ashley, SW; Duxbury, MS; Ito, H; Whang, EE; Zinner, MJ, 2004) |
"We tested the hypotheses that Src tyrosine kinase overactivity represents a chemoresistance mechanism and that Src inhibition may enhance gemcitabine cytotoxicity in pancreatic adenocarcinoma cells." | 3.72 | Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. ( Ashley, SW; Duxbury, MS; Ito, H; Whang, EE; Zinner, MJ, 2004) |
"Although ErbB2 is known to enhance breast cancer metastasis, the signaling events responsible for this remain elusive." | 1.33 | Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors. ( Li, P; Sun, M; Tan, M; Yin, G; Yu, D, 2006) |
"KM12L4A human metastatic colon cancer cells were stably transfected with two distinct kinase-defective mutants of c-src." | 1.32 | Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis. ( Brunton, VG; Cawthorne, C; Dive, C; Frame, MC; Greaves, M; Griffiths, GJ; Koh, MY; Ottley, CJ; Pearson, DG; Reeves, NA; Tilby, MJ; Workman, P, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, X | 1 |
Feng, R | 1 |
Duxbury, MS | 1 |
Ito, H | 1 |
Zinner, MJ | 1 |
Ashley, SW | 1 |
Whang, EE | 1 |
Griffiths, GJ | 1 |
Koh, MY | 1 |
Brunton, VG | 1 |
Cawthorne, C | 1 |
Reeves, NA | 1 |
Greaves, M | 1 |
Tilby, MJ | 1 |
Pearson, DG | 1 |
Ottley, CJ | 1 |
Workman, P | 1 |
Frame, MC | 1 |
Dive, C | 1 |
Tan, M | 1 |
Li, P | 1 |
Sun, M | 1 |
Yin, G | 1 |
Yu, D | 1 |
4 other studies available for ag 1879 and Metastase
Article | Year |
---|---|
Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
Topics: Biomarkers, Tumor; Blotting, Western; Breast Neoplasms; Cadherins; Cell Line; Cell Line, Tumor; Cell | 2010 |
Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting | 2004 |
Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis.
Topics: Apoptosis; bcl-X Protein; Caspase 8; Caspases; Cell Line, Tumor; Colonic Neoplasms; CSK Tyrosine-Pro | 2004 |
Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carbazoles; Cell Line, Tumor; Enzy | 2006 |